Biotest AG 4/A
4/A · ADMA BIOLOGICS, INC. · Filed Nov 16, 2017
Insider Transaction Report
Form 4/AAmended
Biotest AG
Director10% Owner
Transactions
- Purchase
Common Stock
2017-11-09$2.15/sh+5,813,954$12,500,001→ 10,109,534 total(indirect: By Biotest Pharmaceuticals Corporation)
Holdings
- 8,591,160(indirect: By Biotest Pharmaceuticals Corporation)
Non-Voting Common Stock
Footnotes (2)
- [F1]Represents a purchase from the underwriters in the issuer's public offering.
- [F2]The shares are owned directly by Biotest Pharmaceuticals Corporation, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG. Biotest AG is a director and a ten percent owner of the issuer.